Clinical Trial Update: A Study of IBI3032 in Chinese Participants With Overweight or Obesity [Phase 1]

View source ↗

Summary

Phase 1 trial update for IBI3032 in adults with overweight or obesity; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• IBI3032

Snippet

Sponsor: Innovent Biologics Technology Limited (Shanghai R&D Center) | Conditions: Overweight or Obesity | Phase 1 | Status: ACTIVE_NOT_RECRUITING